MENU
+Compare
SOPH
Stock ticker: NASDAQ
AS OF
Dec 2, 04:59 PM (EDT)
Price
$5.10
Change
+$0.26 (+5.37%)
Capitalization
328.79M

SOPH SOPHiA GENETICS SA Forecast, Technical & Fundamental Analysis

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research... Show more

SOPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SOPH with price predictions
Dec 01, 2025

SOPH's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for SOPH moved out of overbought territory on October 31, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SOPH broke above its upper Bollinger Band on October 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on SOPH as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SOPH just turned positive on November 25, 2025. Looking at past instances where SOPH's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

SOPH moved above its 50-day moving average on November 21, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where SOPH advanced for three days, in of 204 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SOPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.417) is normal, around the industry mean (21.383). P/E Ratio (0.000) is within average values for comparable stocks, (104.872). SOPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.432). Dividend Yield (0.000) settles around the average of (0.028) among similar stocks. P/S Ratio (4.439) is also within normal values, averaging (67.016).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

View a ticker or compare two or three
SOPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SOPH is expected to report earnings to fall 26.67% to -21 cents per share on March 10

SOPHiA GENETICS SA SOPH Stock Earnings Reports
Q4'25
Est.
$-0.22
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.11
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.02
The last earnings report on November 04 showed earnings per share of -30 cents, missing the estimate of -23 cents. With 143.79K shares outstanding, the current market capitalization sits at 328.79M.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
La Pièce 12
Phone
+41 216941060
Employees
449
Web
https://www.sophiagenetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFRHF217.713.83
+1.79%
Compagnie Financiere Richemont AG
CRWE1.04N/A
N/A
Crown Equity Holdings, Inc.
PCFBF0.35N/A
N/A
Pacific Basin Shipping Ltd.
WHGPF0.54N/A
N/A
Warehouse Group (THE)
QBCRF37.27-0.07
-0.19%
Quebecor Inc.

SOPH and Stocks

Correlation & Price change

A.I.dvisor tells us that SOPH and RIOT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SOPH and RIOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
-1.50%
RIOT - SOPH
32%
Poorly correlated
-4.03%
TDOC - SOPH
30%
Poorly correlated
-1.98%
COIN - SOPH
30%
Poorly correlated
-4.76%
GMGI - SOPH
29%
Poorly correlated
+13.81%
PSFE - SOPH
28%
Poorly correlated
+3.25%
More

Groups containing SOPH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
-1.50%
Health Services
category (422 stocks)
2%
Poorly correlated
-0.11%
Services to the Health Industry
category (91 stocks)
2%
Poorly correlated
+0.61%